Isofol Medical AB (publ) publishes interim report, January – June 2026
GOTHENBURG, Sweden, August 25, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that […]
mfn-cus-interim-report
Isofol Medical AB (publ) publishes interim report, January – March 2026
GOTHENBURG, Sweden, May 19, 2026 – Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), (”Isofol” or the ”Company”), announced today that